Table 1 |
||||||||
|
Changes in the course of time and overall effect sizes in SETK subscales and SON-R outcome measures |
||||||||
|
T0 Mean ± Sd |
T1 Mean ± Sd |
T2 Mean ± Sd |
T3 Mean ± Sd |
T4 Mean ± Sd |
Fried-man-Test |
Wilcoxon-Test (T1-T4) |
Effectsize(T1-T4) |
|
|
|
||||||||
|
SETK |
||||||||
|
PGN |
37.4 ± 10.2 |
40.0 ± 11.0 |
41.5 ± 14.4 |
44.7 ± 16.3 |
47.0 ± 14.5 |
<0.0005 |
0.002 |
0.45 |
|
VS |
37.4 ± 9.37 |
41.9 ± 12.7 |
43.7 ± 15.4 |
47.0 ± 16.3 |
48.2 ± 16.1 |
0.001 |
0.001 |
0.39 |
|
SG |
30.4 ± 11.4 |
36.9 ± 12.4 |
35.2 ± 14.3 |
36.9 ± 13.5 |
39.9 ± 22.1 |
0.076 |
0.028 |
0.61 |
|
MR |
40.8 ± 12.6 |
42.6 ± 10.7 |
41.6 ± 15.2 |
47.9 ± 17.6 |
46.9 ± 16.5 |
0.116 |
0.054 |
0.19 |
|
GW |
3.0 ± 0.7 |
2.9 ± 1.3 |
3.1 ± 1.2 |
3.1 ± 1.1 |
3.2 ± 1.1 |
0.077 |
0.480 |
0.03 |
|
SON-R (ref-age) |
||||||||
|
HS |
3.2 ± 1.0 |
3.6 ± 1.0 |
4.0 ± 1.0 |
4.0 ± 1.2 |
4.2 ± 1.2 |
<0.0005 |
<0.0005 |
0.61 |
|
DS |
3.5 ± 1.2 |
3.8 ± 1.3 |
4.0 ± 1.0 |
4.3 ± 1.2 |
4.3 ± 1.3 |
<0.0005 |
0.002 |
0.31 |
|
IQ |
3.3 ± 1.1 |
3.7 ± 1.1 |
3.9 ± 1.0 |
4.1 ± 1.2 |
4.3 ± 1.3 |
<0.0005 |
<0.0005 |
0.57 |
|
|
||||||||
|
Groß et al. BMC Complementary and Alternative Medicine 2010 10:39 doi:10.1186/1472-6882-10-39 |
||||||||
